Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)

• Conditions: Uterine Sarcoma

• Registration Number: NCT03493165
• Lead Sponsor: The University of Texas Health Science Center at San Antonio

Brief Summary

Single patient treatment with everolimus.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2018-04-02
• Study First Submitted QC: 2018-04-02
• Study First Posted: 2018-04-10
• Status Verified: 2024-12
• Last Update Submitted: 2024-12-31
• Last Update Posted: 2025-01-01

Recruitment & Eligibility

• Status: AVAILABLE
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: EXPANDED_ACCESS
• Study Design: Not specified